Windlas Biotech Limited
NSE:WINDLAS.NS
859.85 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 6,309.56 | 5,130.83 | 4,633.73 | 4,267.12 | 3,284.3 | 3,052.6 | 3,519.9 |
| Cost of Revenue
| 4,970.76 | 3,254.47 | 3,028.16 | 2,744.05 | 2,115.97 | 1,919.23 | 3,087.06 |
| Gross Profit
| 1,338.8 | 1,876.36 | 1,605.57 | 1,523.07 | 1,168.33 | 1,133.37 | 432.84 |
| Gross Profit Ratio
| 0.212 | 0.366 | 0.346 | 0.357 | 0.356 | 0.371 | 0.123 |
| Reseach & Development Expenses
| 78.77 | 89.48 | 65.11 | 36.06 | 38.74 | 41.87 | 19.58 |
| General & Administrative Expenses
| 0 | 40.12 | 47.69 | 35.5 | 24.16 | 79.42 | 448.49 |
| Selling & Marketing Expenses
| 0 | 146 | 106.82 | 83.91 | 87.93 | 53.18 | 3.43 |
| SG&A
| 691.52 | 186.12 | 154.51 | 119.41 | 112.09 | 132.6 | 169.91 |
| Other Expenses
| 134.68 | 99.65 | 0.77 | 1.98 | 0.28 | 1.69 | -18.61 |
| Operating Expenses
| 691.52 | 1,397.74 | 1,199.68 | 1,079.81 | 843.15 | 830.32 | 208.1 |
| Operating Income
| 647.28 | 478.7 | 402.76 | 434.14 | 322.11 | 301.39 | 224.74 |
| Operating Income Ratio
| 0.103 | 0.093 | 0.087 | 0.102 | 0.098 | 0.099 | 0.064 |
| Total Other Income Expenses Net
| 123.63 | 91.69 | 52.89 | -216.74 | -75.43 | 459.76 | -27.48 |
| Income Before Tax
| 770.91 | 570.39 | 455.65 | 217.4 | 246.68 | 761.15 | 197.26 |
| Income Before Tax Ratio
| 0.122 | 0.111 | 0.098 | 0.051 | 0.075 | 0.249 | 0.056 |
| Income Tax Expense
| 189.04 | 144.13 | 74.76 | 61.7 | 84.55 | 122.93 | 86.52 |
| Net Income
| 581.87 | 426.26 | 380.89 | 158.32 | 162.13 | 638.22 | 111.98 |
| Net Income Ratio
| 0.092 | 0.083 | 0.082 | 0.037 | 0.049 | 0.209 | 0.032 |
| EPS
| 27.97 | 19.7 | 18.58 | 8.7 | 8.9 | 29.28 | 7.06 |
| EPS Diluted
| 27.88 | 19.7 | 18.58 | 8.7 | 8.9 | 29.28 | 6.8 |
| EBITDA
| 781.72 | 701.91 | 575.75 | 320.76 | 354.23 | 406.11 | 398.21 |
| EBITDA Ratio
| 0.124 | 0.137 | 0.124 | 0.075 | 0.108 | 0.133 | 0.113 |